NIH-funded research R01 grant

Investigating how specific proteins affect heart cell activity and fibrosis

Official title: Functional and mechanistic delineation of HuR-Wisp1 signaling on myofibroblast activity

Funded at Ohio State University · NIH-11080335 · Data updated 2026-11-12

This study is looking at how a protein called HuR affects heart cells that help the heart heal after injury, with the goal of finding new ways to treat heart problems caused by scarring.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJune 1, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$649,059
NIH project number5R01HL166326-03
Project IDNIH-11080335 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with cardiac diseases, particularly those experiencing cardiac fibrosis or related conditions.

Less likely to help

Patients with non-cardiac conditions or those without any signs of cardiac fibrosis may not benefit from this research.

What this research studies

This research focuses on understanding how the protein HuR influences the behavior of cardiac fibroblasts, which are cells that play a crucial role in heart remodeling after injury. By studying the signaling pathways involved, the research aims to uncover how these fibroblasts transition into myofibroblasts, which contribute to cardiac fibrosis. The approach includes examining the effects of HuR and its interaction with another protein, Wisp1, to determine their roles in heart cell function and fibrosis. Patients may benefit from insights that could lead to new treatments for heart conditions related to fibrosis.

Why it matters

Potential benefit: If successful, this research could lead to novel therapies that improve heart function and reduce fibrosis in patients with cardiac diseases.

How similar studies have gone: Previous research has shown promising results in manipulating fibroblast activity for therapeutic purposes, indicating potential success for this approach.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Tranter, Michael — Ohio State University
  • Study coordinator: Tranter, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.